Literature DB >> 30580481

The unsolved rare genetic disease atlas? An analysis of the unexplained phenotypic descriptions in OMIM®.

Taila Hartley1, Tuğçe B Balcı2, Samantha K Rojas1, Alison Eaton1, Care Rare Canada1, David A Dyment1,3, Kym M Boycott1,3.   

Abstract

For years, the genetics community has estimated the number of individual rare genetic diseases to be approximately 6,000-8,000. A commonly quoted derivation of this estimate is based on the simple addition of the number of phenotypic entries with and without confirmed molecular etiologies in the Online Mendelian Inheritance in Man (OMIM®). Here, we examine the validity of this estimation by mining the phenotypic entries in OMIM that are of likely or suspected Mendelian inheritance without a molecular cause (MIM number prefix "%" or "null"). Of the 3,204 unsolved phenotypic entries in OMIM, only two-thirds (2,034 entries) represented rare diseases. Of these, 8% were considered "well-established" based on their description in commonly used reference textbooks. We hypothesize based on the large proportion of entries that represent single families reported prior to 2011, that a number of the unsolved entries represent pathogenic variants in known genes. The novel gene discovery potential of these entries is therefore likely lower than originally thought. Given that the majority of the ~300 new disease-gene associations curated each year by OMIM were never associated with a "%" or "null" sign, the true scope of the rare disease atlas is likely much larger than previously anticipated.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mendelian disease; OMIM; disease-gene association; disease-gene discovery; rare disease; unsolved

Mesh:

Year:  2018        PMID: 30580481     DOI: 10.1002/ajmg.c.31662

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  10 in total

1.  Mendelian Gene Discovery: Fast and Furious with No End in Sight.

Authors:  Michael J Bamshad; Deborah A Nickerson; Jessica X Chong
Journal:  Am J Hum Genet       Date:  2019-09-05       Impact factor: 11.025

2.  The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model Organisms.

Authors:  Kym M Boycott; Philippe M Campeau; Heather E Howley; Paul Pavlidis; Sanja Rogic; Christine Oriel; Jason N Berman; Robert M Hamilton; Geoffrey G Hicks; Howard D Lipshitz; Jean-Yves Masson; Eric A Shoubridge; Anne Junker; Michel R Leroux; Christopher R McMaster; Jaques L Michaud; Stuart E Turvey; David Dyment; A Micheil Innes; Clara D van Karnebeek; Anna Lehman; Ronald D Cohn; Ian M MacDonald; Richard A Rachubinski; Patrick Frosk; Anthony Vandersteen; Richard W Wozniak; Izabella A Pena; Xiao-Yan Wen; Thierry Lacaze-Masmonteil; Catharine Rankin; Philip Hieter
Journal:  Am J Hum Genet       Date:  2020-02-06       Impact factor: 11.025

3.  Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling.

Authors:  Macarena López-Sánchez; Carlos Loucera; María Peña-Chilet; Joaquín Dopazo
Journal:  Hum Mol Genet       Date:  2022-06-22       Impact factor: 5.121

4.  Cruxome: a powerful tool for annotating, interpreting and reporting genetic variants.

Authors:  Qingmei Han; Ying Yang; Shengyang Wu; Yingchun Liao; Shuang Zhang; Hongbin Liang; David S Cram; Yu Zhang
Journal:  BMC Genomics       Date:  2021-06-03       Impact factor: 3.969

Review 5.  Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases.

Authors:  Haseeb Nisar; Bilal Wajid; Samiah Shahid; Faria Anwar; Imran Wajid; Asia Khatoon; Mian Usman Sattar; Saima Sadaf
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-15

6.  The Deep Genome Project.

Authors:  K C Kent Lloyd; David J Adams; Gareth Baynam; Arthur L Beaudet; Fatima Bosch; Kym M Boycott; Robert E Braun; Mark Caulfield; Ronald Cohn; Mary E Dickinson; Michael S Dobbie; Ann M Flenniken; Paul Flicek; Sanjeev Galande; Xiang Gao; Anne Grobler; Jason D Heaney; Yann Herault; Martin Hrabě de Angelis; James R Lupski; Stanislas Lyonnet; Ann-Marie Mallon; Fabio Mammano; Calum A MacRae; Roderick McInnes; Colin McKerlie; Terrence F Meehan; Stephen A Murray; Lauryl M J Nutter; Yuichi Obata; Helen Parkinson; Michael S Pepper; Radislav Sedlacek; Je Kyung Seong; Toshihiko Shiroishi; Damian Smedley; Glauco Tocchini-Valentini; David Valle; Chi-Kuang Leo Wang; Sara Wells; Jacqueline White; Wolfgang Wurst; Ying Xu; Steve D M Brown
Journal:  Genome Biol       Date:  2020-02-03       Impact factor: 13.583

7.  The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems.

Authors:  Ainslie Tisdale; Christine M Cutillo; Ramaa Nathan; Pierantonio Russo; Bryan Laraway; Melissa Haendel; Douglas Nowak; Cindy Hasche; Chun-Hung Chan; Emily Griese; Hugh Dawkins; Oodaye Shukla; David A Pearce; Joni L Rutter; Anne R Pariser
Journal:  Orphanet J Rare Dis       Date:  2021-10-22       Impact factor: 4.123

8.  A framework to score the effects of structural variants in health and disease.

Authors:  Philip Kleinert; Martin Kircher
Journal:  Genome Res       Date:  2022-02-23       Impact factor: 9.438

Review 9.  DECIPHER: Supporting the interpretation and sharing of rare disease phenotype-linked variant data to advance diagnosis and research.

Authors:  Julia Foreman; Simon Brent; Daniel Perrett; Andrew P Bevan; Sarah E Hunt; Fiona Cunningham; Matthew E Hurles; Helen V Firth
Journal:  Hum Mutat       Date:  2022-02-21       Impact factor: 4.700

10.  Network Pharmacology Identifies the Mechanisms of Action of TaohongSiwu Decoction Against Essential Hypertension.

Authors:  Tian-Hao Liu; Wei-Hao Chen; Xu-Dong Chen; Qiu-Er Liang; Wen-Cong Tao; Zhen Jin; Ya Xiao; Li-Guo Chen
Journal:  Med Sci Monit       Date:  2020-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.